Rafael Holdings, Inc. (RFL): Net Income
-$29.64M
Year ended 2026-07-31
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2026-07-31 | -$29.64M | n/m | 2026-10-29, From 2025-08-01 |
| 2025-07-31 | -$30.52M | n/m | 2026-10-29, From 2024-08-01 |
| 2024-07-31 | -$34.41M | n/m | 2025-10-29, From 2023-08-01 |
| 2023-07-31 | -$1.88M | n/m | 2024-12-20, From 2022-08-01 |
| 2022-07-31 | -$124.66M | n/c | 2023-10-30, From 2021-08-01 |
| 2021-07-31 | -$23.06M | n/c | 2022-10-31, From 2020-08-01 |
| 2020-07-31 | -$10.75M | n/c | 2021-10-18, From 2019-08-01 |
| 2019-07-31 | -$4.69M | n/m | 2020-10-29, From 2018-08-01 |
| 2018-07-31 | -$11.65M | n/m | 2019-10-04, From 2017-08-01 |
| 2017-07-31 | $138.0K | -80.6% | 2018-10-15, From 2016-08-01 |
| 2016-07-31 | $710.0K | n/a | 2018-10-15, From 2015-08-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | 2026-07-31 | -$29.64M | n/m |
| Rallybio Corp (RLYB) | 2025-12-31 | -$8.98M | n/m |
| Onconetix, Inc. (ONCO) | 2025-12-31 | -$14.03M | n/m |
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | -$48.81M | n/m |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | -$7.37M | n/m |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | -$13.40M | n/m |
| Lexaria Bioscience Corp. (LEXX) | 2025-08-31 | -$11.90M | n/m |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | -$6.21M | n/m |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | -$13.45M | n/m |
Compare RFL, RLYB, ONCO, STTK side by side · Screen every company in Pharmaceutical Preparations ↗